Our One-Minute Series on NGS
With our One-Minute Series, we bring concise, expert-driven videos that break down essential NGS topics into clear insights.
OUR LATEST EPISODE
Episode 8: Do I really need to perform a comparability run between NGS and classical biosafety tests?
Colette Côté, US General Manager, Chief Scientific and Portfolio Officer of PathoQuest
Episode 7: What are the regulatory tools to support NGS testing in your IND/IMPD?
Stanley Prince, CCO of PathoQuest
Episode 6: How does NGS reduce time to market in Biopharma?
Colette Côté, US General Manager, Chief Scientific and Portfolio Officer of PathoQuest
Episode 5: How does NGS fit within my modality?
Stanley Prince, CCO of PathoQuest
Episode 4: Is NGS testing in biopharma a possible alternative to animal virus testing?
Jean-François Brepson, CEO of PathoQuest
Episode 3: Is NGS testing in biopharma approved by regulators and industry?
Jean-François Brepson, CEO of PathoQuest
Episode 2: Is NGS testing in biopharma validated to GMP standards?
Jean-François Brepson, CEO of PathoQuest
Episode 1: Why adopt NGS for Quality Control in Biopharma?
Jean-François Brepson, CEO of PathoQuest
Contact us
France
+33 (0)1 70 82 17 90
Biopark -Bâtiment B,
11, rue Watt
75013 Paris, France
How can PathoQuest help?
U.S.
466 Devon Park Dr
Wayne, PA 19087
United States
France
+33 (0)1 70 82 17 90
Biopark -Bâtiment B,
11, rue Watt
75013 Paris, France
How can PathoQuest help?
Sign up for our latest news
